Manish Goel
About Manish Goel
SEBI Registered Research Analyst • Chartered Accountant
377 Articles Published
Manish Goel is a Chartered Accountant, SEBI Registered Research Analyst, and founder of Manish Goel PMS. A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.
May 18, 2026
How to read the Vigil Mechanism / Whistleblower Policy section of an Indian Annual Report — the three overlapping laws, the five-component checklist, and what Titan Biotech FY25's governance markers illustrate. Educational only — not a buy/sell call.
May 18, 2026
Buffett's four filters — understandable business, favourable economics, able-and-trustworthy management, sensible price — applied step by step to Titan Biotech's FY25 audited numbers, in their canonical sequential order.
May 17, 2026
The Ostrich Effect — documented by Karlsson, Loewenstein & Seppi in 2009 — explains why Indian investors stop checking portfolios during market corrections. Brokerage logins fall 9.5% on down-1% days. We walk through the academic foundation, Indian SIP-discontinuation and demat-dormancy data, a seven-step counter-measure checklist, and Titan Biotech's FY25 disclosure architecture as an illustrative anti-ostrich case study.
May 17, 2026
Board meeting frequency is the cheapest forensic governance signal hidden in every Indian annual report. SEBI LODR Reg 17(2) sets the floor at 4, best-practice boards meet 8-12 times, and Titan Biotech FY25 illustrates the disciplined end with 14 meetings sitting alongside a fortress balance sheet.